January 3, 2024 · Form 4 insider transaction
Fenimore Christopher R. bought 5,000 shares of Regeneron Pharmaceuticals, Inc. at $555.67 per share, a transaction worth $2.78M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.